CTLA4 and neoplasm: Despite the favorable results, a preclinical study combining magnetic iron oxide nanoparticle hyperthermia and anti-PD-1 and anti-CTLA-4 with a 4T1-luc cell mouse model also showed decreased tumor volume but increased metastatic dissemination and no improvement in overall survival (128).